Atlas Trials

Open Label, Study Of Efficacy and Safety Of AVR-RD-01 for Treatment-Naive Subjects With Classic Fabry Disease

Clinical trial NCT03454893 · TERMINATED

Trial details

NCT number
NCT03454893
Sponsor
AVROBIO
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Fabry Disease
Start date
2018-02-21
Primary completion
2022-03-14
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.